Using mRNA as a therapeutic
is a cutting-edge approach

mRNA technologies open unprecedented opportunities to advance disease treatment and prevention.

With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform and therapies to pharmaceutical partners.

We are proudly introducing novel cap analogs offering a range of advantages for your mRNA vaccines and therapeutics.

AvantCap AG High yields and capping efficiencies
Enhanced translation
ExploCap Delivers high IVT yields and capping efficiencies
AvantCap Q1 Delivers high yields and capping efficiencies across a wide range of IVT conditions
AvantCap Q2 Delivers Cap 2 modification with high yields and capping efficiencies across a wide range of IVT conditions

Our Team

ExploRNA is led by Professor Jacek Jemielity, esteemed scientific leader and inventor with vast experience in mRNA biochemistry field. Spinning out from the University of Warsaw the kernel of the company is a team of top-level scientists with chemical, biology and immunology expertise. The founders of ExploRNA Therapeutics have unique experience in working with mRNA and are inventors of ground-breaking solutions, which have already found commercial application.

Jacek Jemielity Chief Executive Officer
Joanna Kowalska Chief Technology Officer
Jakub Gołąb Chief Scientific Officer
Mateusz Gołąb Board Member, Chief Financial Officer
Tomasz Piec Board Member
Dominika Nowis Director of Biology
Marek Baranowski Director of Research and Quality Development
Piotr Stępniak Director of Business Development

Our mission is to deliver mRNA technology innovations to revolutionize future therapies and prevention of many diseases.

We invent, develop, manufacture and apply our solutions for the benefit of pharmaceutical partners to improve people’s lives.

Our focus is on innovations of the mRNA platform, including novel cap analogs
News

March 3, 2025

ExploRNA @ RNA Leaders Europe Congress in Basel Read more

February 28, 2025

Prof. Jacek Jemielity invited to give a seminar at the RNA Therapeutics Institute UMass Chan Medical School Read more

October 2, 2024

ExploRNA at the Polish Embassy in Tokyo and BioJapan 2024 in Yokohama! Read more

September 3, 2024

Primrose Bio and ExPLoRNA Therapeutics Announce Strategic Partnership to Advance mRNA Medicines Read more

August 22, 2024

Meet ExploRNA’s CEO at PHASE2024 in Warsaw Read more

March 8, 2024

AvantCap publication in JACS Read more

February 28, 2024

ExploRNA joins the Alliance for mRNA Medicines Read more

August 16, 2023

ExploRNA at PHASE2023 Read more